Roche nabs blockbuster FDA approval for Hemlibra, big label expansion for Gazyva

16th November 2017 Uncategorised 0

Call it a big day for Roche at the FDA, as the drug giant picked up two critical approvals on Thursday, first for hemophilia A drug Hemlibra and then with a label expansion for Gazyva.

More: Roche nabs blockbuster FDA approval for Hemlibra, big label expansion for Gazyva
Source: fierce